Power Law company profile

Repare Therapeutics

Biotech & Life Sciences · Montreal, Canada · Founded 2016 · IPO 2020 Thoroughbred

Develops precision cancer therapies using synthetic lethality and CRISPR-based discovery platforms

Valuation

$2.0M

Market cap · Feb/2026

Revenue

$53M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

9 investors on Repare Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

MPM BioImpact

Versant Ventures

Series B+ 7 investors entered at this stage

Logos Capital

OrbiMed

BVF Partners

Fonds de solidarité FTQ

Cowen Healthcare Investments

BDC Capital

Redmile Group

Global footprint

Where Repare Therapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States57.4%

🇨🇦 Canada41%

🇲🇽 Mexico1.4%

🇫🇷 France0.9%

4 countries shown

Web traffic by country

8.9K monthly visits
across markets

🇺🇸 United States58.4%

🇨🇦 Canada27%

🇯🇵 Japan10.1%

🇩🇪 Germany3.4%

🇬🇧 United Kingdom2.2%

Top 5 markets shown

Market sentiment

What the market is saying about Repare Therapeutics

An AI-synthesized read of the highest-engagement posts about Repare Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Repare Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles